DEVELOPMENT OF HINGWASTAK CHURNA GRANULES AND TABLETS BY DRY GRANULATION TECHNIQUE FOR IMPROVING PATIENT COMPLIANCE

Ayurvedic formulary of India specifies the dose of Hingwastak churna to be 3-6 grams per day. It is difficult to swallow churna for patients. The objective of the present study was to develop Hingwastak churna granules and tablets with addition of organoleptic additives to improve the patient compliance. Granules and tablet formulations were developed by dry granulation (slugging) technique using different binders and other excipients. The granules were evaluated for angle of repose, tapped densities, compressibility index, organoleptic studies and stability study. The tablets were evaluated for weight uniformity, thickness, hardness, friability and disintegration time. Among the binding agents used 10% Avicel, CaCO3 and starch produced better granules with sufficient hardness and good flow properties. All the volunteers concurrently accepted the taste of Hingwastak churna granule formulation. Suitable formulation strategy can overcome the existing problem of Hingwastak churna.